Methylation-Sensitive Amplification Length Polymorphism (MS-AFLP) Microarrays for Epigenetic Analysis of Human Genomes View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2018-04-01

AUTHORS

Sergio Alonso , Koichi Suzuki , Fumiichiro Yamamoto , Manuel Perucho

ABSTRACT

Somatic, and in a minor scale also germ line, epigenetic aberrations are fundamental to carcinogenesis, cancer progression, and tumor phenotype. DNA methylation is the most extensively studied and arguably the best understood epigenetic mechanisms that become altered in cancer. Both somatic loss of methylation (hypomethylation) and gain of methylation (hypermethylation) are found in the genome of malignant cells. In general, the cancer cell epigenome is globally hypomethylated, while some regions—typically gene-associated CpG islands—become hypermethylated. Given the profound impact that DNA methylation exerts on the transcriptional profile and genomic stability of cancer cells, its characterization is essential to fully understand the complexity of cancer biology, improve tumor classification, and ultimately advance cancer patient management and treatment. A plethora of methods have been devised to analyze and quantify DNA methylation alterations. Several of the early-developed methods relied on the use of methylation-sensitive restriction enzymes, whose activity depends on the methylation status of their recognition sequences. Among these techniques, methylation-sensitive amplification length polymorphism (MS-AFLP) was developed in the early 2000s, and successfully adapted from its original gel electrophoresis fingerprinting format to a microarray format that notably increased its throughput and allowed the quantification of the methylation changes. This array-based platform interrogates over 9500 independent loci putatively amplified by the MS-AFLP technique, corresponding to the NotI sites mapped throughout the human genome. More... »

PAGES

137-156

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-4939-7768-0_8

DOI

http://dx.doi.org/10.1007/978-1-4939-7768-0_8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1101883947

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29605851


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0604", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Genetics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Amplified Fragment Length Polymorphism Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CpG Islands", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA Fingerprinting", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA Methylation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA Restriction Enzymes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Epigenesis, Genetic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genetic Loci", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genome, Human", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oligonucleotide Array Sequence Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transcription, Genetic", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Program of Predictive and Personalized Medicine of Cancer (PMPPC), Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Program of Predictive and Personalized Medicine of Cancer (PMPPC), Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Alonso", 
        "givenName": "Sergio", 
        "id": "sg:person.01240515061.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240515061.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.416093.9", 
          "name": [
            "Department of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Suzuki", 
        "givenName": "Koichi", 
        "id": "sg:person.011217265234.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011217265234.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Program of Predictive and Personalized Medicine of Cancer (PMPPC), Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain", 
          "id": "http://www.grid.ac/institutes/grid.429289.c", 
          "name": [
            "Program of Predictive and Personalized Medicine of Cancer (PMPPC), Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yamamoto", 
        "givenName": "Fumiichiro", 
        "id": "sg:person.0744112523.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744112523.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Program of Predictive and Personalized Medicine of Cancer (PMPPC), Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Program of Predictive and Personalized Medicine of Cancer (PMPPC), Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Perucho", 
        "givenName": "Manuel", 
        "id": "sg:person.01000314671.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01000314671.43"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2018-04-01", 
    "datePublishedReg": "2018-04-01", 
    "description": "Somatic, and in a minor scale also germ line, epigenetic aberrations are fundamental to carcinogenesis, cancer progression, and tumor phenotype. DNA methylation is the most extensively studied and arguably the best understood epigenetic mechanisms that become altered in cancer. Both somatic loss of methylation (hypomethylation) and gain of methylation (hypermethylation) are found in the genome of malignant cells. In general, the cancer cell epigenome is globally hypomethylated, while some regions\u2014typically gene-associated CpG islands\u2014become hypermethylated. Given the profound impact that DNA methylation exerts on the transcriptional profile and genomic stability of cancer cells, its characterization is essential to fully understand the complexity of cancer biology, improve tumor classification, and ultimately advance cancer patient management and treatment.\nA plethora of methods have been devised to analyze and quantify DNA methylation alterations. Several of the early-developed methods relied on the use of methylation-sensitive restriction enzymes, whose activity depends on the methylation status of their recognition sequences. Among these techniques, methylation-sensitive amplification length polymorphism (MS-AFLP) was developed in the early 2000s, and successfully adapted from its original gel electrophoresis fingerprinting format to a microarray format that notably increased its throughput and allowed the quantification of the methylation changes. This array-based platform interrogates over 9500 independent loci putatively amplified by the MS-AFLP technique, corresponding to the NotI sites mapped throughout the human genome.", 
    "editor": [
      {
        "familyName": "Vavouri", 
        "givenName": "Tanya", 
        "type": "Person"
      }, 
      {
        "familyName": "Peinado", 
        "givenName": "Miguel A.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-4939-7768-0_8", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-4939-7767-3", 
        "978-1-4939-7768-0"
      ], 
      "name": "CpG Islands", 
      "type": "Book"
    }, 
    "keywords": [
      "human genome", 
      "DNA methylation", 
      "methylation-sensitive restriction enzymes", 
      "cancer cell epigenome", 
      "DNA methylation alterations", 
      "gain of methylation", 
      "array-based platforms", 
      "cell epigenome", 
      "genomic stability", 
      "epigenetic mechanisms", 
      "transcriptional profiles", 
      "methylation changes", 
      "methylation alterations", 
      "epigenetic analysis", 
      "independent loci", 
      "NotI sites", 
      "recognition sequence", 
      "epigenetic aberrations", 
      "restriction enzymes", 
      "genome", 
      "methylation status", 
      "methylation", 
      "cancer biology", 
      "somatic loss", 
      "cancer progression", 
      "length polymorphism", 
      "cancer cells", 
      "tumor phenotype", 
      "microarray format", 
      "epigenome", 
      "malignant cells", 
      "cells", 
      "loci", 
      "biology", 
      "microarrays", 
      "plethora of methods", 
      "phenotype", 
      "profound impact", 
      "enzyme", 
      "CpG", 
      "sequence", 
      "polymorphism", 
      "cancer patient management", 
      "carcinogenesis", 
      "plethora", 
      "sites", 
      "aberrations", 
      "alterations", 
      "mechanism", 
      "characterization", 
      "activity", 
      "lines", 
      "progression", 
      "region", 
      "tumor classification", 
      "minor scale", 
      "loss", 
      "cancer", 
      "changes", 
      "profile", 
      "analysis", 
      "quantification", 
      "status", 
      "impact", 
      "stability", 
      "platform", 
      "complexity", 
      "treatment", 
      "scale", 
      "gain", 
      "use", 
      "classification", 
      "method", 
      "technique", 
      "format", 
      "management", 
      "throughput", 
      "patient management", 
      "gene-associated CpG", 
      "methylation-sensitive amplification length polymorphism", 
      "amplification length polymorphism", 
      "original gel electrophoresis fingerprinting format", 
      "gel electrophoresis fingerprinting format", 
      "electrophoresis fingerprinting format", 
      "fingerprinting format", 
      "MS-AFLP technique", 
      "Methylation-Sensitive Amplification Length Polymorphism (MS-AFLP) Microarrays", 
      "Amplification Length Polymorphism (MS-AFLP) Microarrays", 
      "Length Polymorphism (MS-AFLP) Microarrays", 
      "Polymorphism (MS-AFLP) Microarrays"
    ], 
    "name": "Methylation-Sensitive Amplification Length Polymorphism (MS-AFLP) Microarrays for Epigenetic Analysis of Human Genomes", 
    "pagination": "137-156", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1101883947"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-4939-7768-0_8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29605851"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-4939-7768-0_8", 
      "https://app.dimensions.ai/details/publication/pub.1101883947"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2021-11-01T18:48", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/chapter/chapter_161.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-1-4939-7768-0_8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-4939-7768-0_8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-4939-7768-0_8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-4939-7768-0_8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-4939-7768-0_8'


 

This table displays all metadata directly associated to this object as RDF triples.

238 TRIPLES      23 PREDICATES      129 URIs      122 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-4939-7768-0_8 schema:about N0cc7369ce1d044678d534a5d2e52d797
2 N33eeadcf3ae3476cae7734a178716423
3 N7af9f0c96ecc457baf49c724975c7dbe
4 N85b1b35a34f447539c4d73db3982caf5
5 Na5428812c7fc4b238007bd9d0e8ff248
6 Nacb8128afa41406e92125f64a46d66c5
7 Ncac1e0ead43d4cb4b354592f94ea4531
8 Nd1135fc1a73f454180b1dcebbbb166b4
9 Ndf90a9e43044485eac98744c3523ee5f
10 Ne7f6388fcb1e4a5b894df5aa51e33b4b
11 Nf2b20d28830f44878ee92502bbc27fcc
12 Nfbe5e8fe609744039b205abb1eb8f7b9
13 Nfd944b1d560549669f3bb372399a520f
14 anzsrc-for:06
15 anzsrc-for:0604
16 schema:author Nd236bd08fef64d2abeaae7e50bb54931
17 schema:datePublished 2018-04-01
18 schema:datePublishedReg 2018-04-01
19 schema:description Somatic, and in a minor scale also germ line, epigenetic aberrations are fundamental to carcinogenesis, cancer progression, and tumor phenotype. DNA methylation is the most extensively studied and arguably the best understood epigenetic mechanisms that become altered in cancer. Both somatic loss of methylation (hypomethylation) and gain of methylation (hypermethylation) are found in the genome of malignant cells. In general, the cancer cell epigenome is globally hypomethylated, while some regions—typically gene-associated CpG islands—become hypermethylated. Given the profound impact that DNA methylation exerts on the transcriptional profile and genomic stability of cancer cells, its characterization is essential to fully understand the complexity of cancer biology, improve tumor classification, and ultimately advance cancer patient management and treatment. A plethora of methods have been devised to analyze and quantify DNA methylation alterations. Several of the early-developed methods relied on the use of methylation-sensitive restriction enzymes, whose activity depends on the methylation status of their recognition sequences. Among these techniques, methylation-sensitive amplification length polymorphism (MS-AFLP) was developed in the early 2000s, and successfully adapted from its original gel electrophoresis fingerprinting format to a microarray format that notably increased its throughput and allowed the quantification of the methylation changes. This array-based platform interrogates over 9500 independent loci putatively amplified by the MS-AFLP technique, corresponding to the NotI sites mapped throughout the human genome.
20 schema:editor Nfb4e3defcd5b4835895cb775bcd87b06
21 schema:genre chapter
22 schema:inLanguage en
23 schema:isAccessibleForFree false
24 schema:isPartOf N230a01218c8842d8ab07021fa9d1c9a5
25 schema:keywords Amplification Length Polymorphism (MS-AFLP) Microarrays
26 CpG
27 DNA methylation
28 DNA methylation alterations
29 Length Polymorphism (MS-AFLP) Microarrays
30 MS-AFLP technique
31 Methylation-Sensitive Amplification Length Polymorphism (MS-AFLP) Microarrays
32 NotI sites
33 Polymorphism (MS-AFLP) Microarrays
34 aberrations
35 activity
36 alterations
37 amplification length polymorphism
38 analysis
39 array-based platforms
40 biology
41 cancer
42 cancer biology
43 cancer cell epigenome
44 cancer cells
45 cancer patient management
46 cancer progression
47 carcinogenesis
48 cell epigenome
49 cells
50 changes
51 characterization
52 classification
53 complexity
54 electrophoresis fingerprinting format
55 enzyme
56 epigenetic aberrations
57 epigenetic analysis
58 epigenetic mechanisms
59 epigenome
60 fingerprinting format
61 format
62 gain
63 gain of methylation
64 gel electrophoresis fingerprinting format
65 gene-associated CpG
66 genome
67 genomic stability
68 human genome
69 impact
70 independent loci
71 length polymorphism
72 lines
73 loci
74 loss
75 malignant cells
76 management
77 mechanism
78 method
79 methylation
80 methylation alterations
81 methylation changes
82 methylation status
83 methylation-sensitive amplification length polymorphism
84 methylation-sensitive restriction enzymes
85 microarray format
86 microarrays
87 minor scale
88 original gel electrophoresis fingerprinting format
89 patient management
90 phenotype
91 platform
92 plethora
93 plethora of methods
94 polymorphism
95 profile
96 profound impact
97 progression
98 quantification
99 recognition sequence
100 region
101 restriction enzymes
102 scale
103 sequence
104 sites
105 somatic loss
106 stability
107 status
108 technique
109 throughput
110 transcriptional profiles
111 treatment
112 tumor classification
113 tumor phenotype
114 use
115 schema:name Methylation-Sensitive Amplification Length Polymorphism (MS-AFLP) Microarrays for Epigenetic Analysis of Human Genomes
116 schema:pagination 137-156
117 schema:productId N6dba5f2cb8374452b04736b3178dad76
118 N82da713471584d4fbb12a3aac476a77c
119 Ndee0e9fdda35471da9eec74338bc1885
120 schema:publisher N59c1cd28603b4325aec4ddb306329b22
121 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101883947
122 https://doi.org/10.1007/978-1-4939-7768-0_8
123 schema:sdDatePublished 2021-11-01T18:48
124 schema:sdLicense https://scigraph.springernature.com/explorer/license/
125 schema:sdPublisher N9de6dcaf8a0d40f8b90c7dd1ae377e5f
126 schema:url https://doi.org/10.1007/978-1-4939-7768-0_8
127 sgo:license sg:explorer/license/
128 sgo:sdDataset chapters
129 rdf:type schema:Chapter
130 N0cc7369ce1d044678d534a5d2e52d797 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Epigenesis, Genetic
132 rdf:type schema:DefinedTerm
133 N1228ac44c47945e0a79fdd3e7cc613bc rdf:first N26115bf403a74766996cad8a3ddc4ce9
134 rdf:rest rdf:nil
135 N230a01218c8842d8ab07021fa9d1c9a5 schema:isbn 978-1-4939-7767-3
136 978-1-4939-7768-0
137 schema:name CpG Islands
138 rdf:type schema:Book
139 N26115bf403a74766996cad8a3ddc4ce9 schema:familyName Peinado
140 schema:givenName Miguel A.
141 rdf:type schema:Person
142 N33eeadcf3ae3476cae7734a178716423 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name DNA Methylation
144 rdf:type schema:DefinedTerm
145 N3af1b7516b6449568845bd281f06a36f rdf:first sg:person.01000314671.43
146 rdf:rest rdf:nil
147 N59c1cd28603b4325aec4ddb306329b22 schema:name Springer Nature
148 rdf:type schema:Organisation
149 N6347962e4a4d4f6c88d15a7eceb24b07 rdf:first sg:person.0744112523.60
150 rdf:rest N3af1b7516b6449568845bd281f06a36f
151 N6dba5f2cb8374452b04736b3178dad76 schema:name dimensions_id
152 schema:value pub.1101883947
153 rdf:type schema:PropertyValue
154 N7a54fb67148d4db38ced37e04feaaf00 rdf:first sg:person.011217265234.09
155 rdf:rest N6347962e4a4d4f6c88d15a7eceb24b07
156 N7af9f0c96ecc457baf49c724975c7dbe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name DNA Restriction Enzymes
158 rdf:type schema:DefinedTerm
159 N82da713471584d4fbb12a3aac476a77c schema:name pubmed_id
160 schema:value 29605851
161 rdf:type schema:PropertyValue
162 N85b1b35a34f447539c4d73db3982caf5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name DNA
164 rdf:type schema:DefinedTerm
165 N9de6dcaf8a0d40f8b90c7dd1ae377e5f schema:name Springer Nature - SN SciGraph project
166 rdf:type schema:Organization
167 Na5428812c7fc4b238007bd9d0e8ff248 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Transcription, Genetic
169 rdf:type schema:DefinedTerm
170 Nacb8128afa41406e92125f64a46d66c5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Oligonucleotide Array Sequence Analysis
172 rdf:type schema:DefinedTerm
173 Nbcea92fc0dee4b4c81b834b97d48e7cd schema:familyName Vavouri
174 schema:givenName Tanya
175 rdf:type schema:Person
176 Ncac1e0ead43d4cb4b354592f94ea4531 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name DNA Fingerprinting
178 rdf:type schema:DefinedTerm
179 Nd1135fc1a73f454180b1dcebbbb166b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Neoplasms
181 rdf:type schema:DefinedTerm
182 Nd236bd08fef64d2abeaae7e50bb54931 rdf:first sg:person.01240515061.54
183 rdf:rest N7a54fb67148d4db38ced37e04feaaf00
184 Ndee0e9fdda35471da9eec74338bc1885 schema:name doi
185 schema:value 10.1007/978-1-4939-7768-0_8
186 rdf:type schema:PropertyValue
187 Ndf90a9e43044485eac98744c3523ee5f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Genome, Human
189 rdf:type schema:DefinedTerm
190 Ne7f6388fcb1e4a5b894df5aa51e33b4b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Amplified Fragment Length Polymorphism Analysis
192 rdf:type schema:DefinedTerm
193 Nf2b20d28830f44878ee92502bbc27fcc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Genetic Loci
195 rdf:type schema:DefinedTerm
196 Nfb4e3defcd5b4835895cb775bcd87b06 rdf:first Nbcea92fc0dee4b4c81b834b97d48e7cd
197 rdf:rest N1228ac44c47945e0a79fdd3e7cc613bc
198 Nfbe5e8fe609744039b205abb1eb8f7b9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
199 schema:name Humans
200 rdf:type schema:DefinedTerm
201 Nfd944b1d560549669f3bb372399a520f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
202 schema:name CpG Islands
203 rdf:type schema:DefinedTerm
204 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
205 schema:name Biological Sciences
206 rdf:type schema:DefinedTerm
207 anzsrc-for:0604 schema:inDefinedTermSet anzsrc-for:
208 schema:name Genetics
209 rdf:type schema:DefinedTerm
210 sg:person.01000314671.43 schema:affiliation grid-institutes:None
211 schema:familyName Perucho
212 schema:givenName Manuel
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01000314671.43
214 rdf:type schema:Person
215 sg:person.011217265234.09 schema:affiliation grid-institutes:grid.416093.9
216 schema:familyName Suzuki
217 schema:givenName Koichi
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011217265234.09
219 rdf:type schema:Person
220 sg:person.01240515061.54 schema:affiliation grid-institutes:None
221 schema:familyName Alonso
222 schema:givenName Sergio
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240515061.54
224 rdf:type schema:Person
225 sg:person.0744112523.60 schema:affiliation grid-institutes:grid.429289.c
226 schema:familyName Yamamoto
227 schema:givenName Fumiichiro
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744112523.60
229 rdf:type schema:Person
230 grid-institutes:None schema:alternateName Program of Predictive and Personalized Medicine of Cancer (PMPPC), Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain
231 schema:name Program of Predictive and Personalized Medicine of Cancer (PMPPC), Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain
232 rdf:type schema:Organization
233 grid-institutes:grid.416093.9 schema:alternateName Department of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Japan
234 schema:name Department of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Japan
235 rdf:type schema:Organization
236 grid-institutes:grid.429289.c schema:alternateName Program of Predictive and Personalized Medicine of Cancer (PMPPC), Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain
237 schema:name Program of Predictive and Personalized Medicine of Cancer (PMPPC), Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain
238 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...